Innovation Pharmaceuticals Inc (IPIX)

[mdphd2008]

I personally don't mind waiting a few short months until December to see full top line results for prurisol trial. Rushing to see interim results may not give as a dramatic effect of efficacy (study was designed with the number of patients chosen to see statistics significance with full enrollment). Interim results are often useful to show safety, however with prurisol, based on the extensive history of abacavir use and it's close similarities, safety is not a major concern. If final trial results were a year away, I would be more curious to see interim results. Again, to me personally, I don't mind the small wait.